FAMILY

  • Research type

    Research Study

  • Full title

    Faecal Microbiota Analysis in Neurotypical and Autism Syndrome Disorder Siblings

  • IRAS ID

    317085

  • Contact name

    Ben Marlow

  • Contact email

    benjamin.marlow@nhs.net

  • Sponsor organisation

    East Suffolk and North Essex NHS Foundation Trust

  • Clinicaltrials.gov Identifier

    TBC, Clinicaltrials.gov registration post approval

  • Duration of Study in the UK

    0 years, 6 months, 31 days

  • Research summary

    Autism Spectrum Disorder (ASD) is a group of brain developmental disorders defined by stereotyped behaviour and deficits in communication and social interaction (David et al 2021). ASD is often associated with gastrointestinal (GI) comorbidities (Wasilewska et al 2015). GI symptoms tend to be correlated with the severity of the ASD symptoms (Chaidez et al 2014). The mechanisms underpinning the connection between GI clinical signs and ASD remain largely unknown. However, evidence suggests the link may be the gut microbiota (the bacteria, archaea, viruses and eukaryotes in the human gut) that interact with the human host via the gut-brain axis (Cryan et al 2013).

    This study aims to firstly characterise the gut microbiota composition of faeces of children with ASD compared with the gut microbiota composition of their neurotypical sibling. Secondly, whole-genome sequencing (WGS) and nuclear magnetic resonance (NMR) spectroscopy will be used to characterise the metagenome and metabolome of the faeces of both the children with ASD and their neurotypical sibling. It is hypothesised that firstly the gut microbiota composition of the faeces of children with ASD will be significantly different from their siblings’. Secondly, the functionality of the gut microbiota will be impaired and will lack genes encoding key functions in those with ASD, in comparison with their sibling.If such comparisons can be demonstrated this will add to the evidence base for use of potential therapeutic strategies for children with ASD, such as faecal transplant with a sibling acting as donor.

    This is a pilot study, which will allow the research team to calculate the required sample size for a larger powered study that will definitely explore whether the gut microbiota composition is different between siblings with ASD and their neurotypical sibling.

  • REC name

    Yorkshire & The Humber - Leeds East Research Ethics Committee

  • REC reference

    22/YH/0219

  • Date of REC Opinion

    11 Nov 2022

  • REC opinion

    Further Information Favourable Opinion